In a sneak peek at athenahealth’s plans for the HIMSS23 Conference and Exhibition this April, CEO Bob Segert said that a key highlight will be the company’s focus on improving the patient creating a…
Continue Reading
To this day, reproductive care remains fragmented, expensive and inaccessible. A lack of solutions to solve these problems has led to the proliferation of startups attempting to plug care gaps. After speaking with over 75…
Continue Reading
Ampersand Health has created a remote monitoring platform for clinicians, aimed at prolonging periods of remission for patients with long-term inflammatory conditions.The platform supports hospitals to deliver safer, proactive and more personalised care to…
Continue Reading
By Sarai Rodriguez March 17, 2023 – The healthcare sector faces a new cybersecurity threat as the Black Basta ransomware group emerges, the Health Sector Cybersecurity Coordination Center (HC3) warned in a threat profile. The…
Continue Reading
In todays fast-paced world, it is easy to miss out on important information, especially if you are trying to keep up with a lot of different sources. That is where the daily digest comes in – it is a tool that compiles all the posts created on the previous day, providing you with a convenient […]
Continue Reading
To drive health innovation that meets the needs of all and democratize healthcare, there is a need to assess the generalization performance of deep learning (DL) algorithms across various distribution shifts to ensure that…
Continue Reading
Telstra Health names new CTOFarhoud Salimi, eHealth NSW executive director of service delivery, is filling up the vacant CTO role at Telstra Health.
He will be assuming the position starting on 17 April, succeeding Russel…
Jonathan Perlin, CEO of the Joint Commisssion
As I write this article, I am recovering from a power outage that lasted nearly two days due to trees downed by record winds created by the atmospheric…
The Food and Drug Administration’s Dr. Robert Califf called on insurers Thursday to help ensure that studies on new drugs in the accelerated approval pathway are still completed.
“I don’t think it’s just a matter…
